Hieff Trans™ UltraAAV Transfection Reagent (PEI) _ 40823ES yeasen
$95.00
In stock
SKU
40823ES01
Product Description
This product is a linearized polyethyleneimine (Polyethylenimine Linear, PEI) specially developed for the large-scale production of AAV in suspension culture systems. It is a chemically synthesized product, free of animal-derived components, with low cytotoxicity. The product is provided in sterile liquid form and has a wide applicability for various AAV serotypes. It features strong DNA loading capacity, low transfection complex ratio, and high complex stability, facilitating large-scale AAV and protein production.
Features
- Optimized for AAV Manufacturing:
- Specially developed for large-scale recombinant AAV production in suspension 293 cell lines.
- Superior Packaging Efficiency:
- Achieves a doubled full capsid ratio with 10× higher efficiency compared to standard PEI.
- Reduced Reagent Usage:
- Delivers equivalent transfection efficiency with just 1/4 the amount of PEI, cutting reagent input in half.
- Cost-Effective:
- Lower consumption directly reduces overall production cost.
- High Transfection Performance:
- Ensures robust and reliable transfection across a wide range of applications.
- Regulatory Advantage:
- GMP-ready with DMF filing support, accelerating project approval and commercialization.
Applications
- Production of AAV/LV Viral Vectors
- Protein production
Specifications
- Form
- liquid
- Properties
- Polyethylenimine Linear (PEI)
- Virus Type
- AAV
Components
- Components No.
- Name
- 40823ES01
- 40823ES03
- 40823ES10
- 40823ES60
- 40823
- Hieff Trans™
- UltraAAV Transfection Reagent
- 100
- μ
- L
- 1 mL
- 10 mL
- 100 mL
Shipping and Storage
Hieff Trans™ UltraAAV Transfection Reagent products should be stored at 2-8 ℃ for 2 year.
Figures
1. Cost-Efficient & Minimal Reagent Use
Figure 1. Hieff Trans™ UltraAAV achieves more with less—minimizing reagent input while maximizing protein production efficiency. 2. High-efficiency transfection
Figure 2. Comparison of transfection performance between Yeasen Hieff TransTM (PEI AAV) and Control PEI(FectorVIR-AAV). Hieff TransTM requires only half the reagent input yet still achieves higher viral yield than Control PEI. At equivalent viral production, the cost of transfection reagent is reduced by 50%. 3. Maximized AAV Yield
Figure 3. Hieff Trans™ UltraAAV maximizes AAV yield across multiple serotypes. Superior transfection efficiency was observed compared with leading PEIs. AAV2, AAV5, AAV8, and AAV9 were produced in suspension 293F cells using 1 µg DNA per million cells. Viral particles were harvested 72 hours post-transfection, and supernatants were analyzed. 4. Strong Stability
Figure 4. Stability evaluation in the AAV9 project. Hieff TransTM demonstrated consistent performance across three GMP-grade batches and passed both accelerated and transport stability testing, ensuring reliable and stable supply. Related Reading Revolutionary PEI-Mediated Gene Delivery for Superior Transfection Efficiency
Safety Data Sheet
- 40823
- _MSDS_HB
- 250121
- _EN.PDF
Manuals
- 40823
- _Manual_HB2
- 50121
- _EN.pdf
Reviews
Write Your Own Review
Related Products
Check items to add to the cart or
